Enero Group Limited · ASX:EGG
Enero — H1 FY2026 Earnings Presentation
19 slides from Enero's earnings presentation, Feb 19, 2026
Slide 1: Enero Group FY26 H1 Results
Enero Group FY26 H1 Results 19 February 2026
Slide 2: Continuing operations doubled net profit and EPS
1 Continuing operations doubled net profit and EPS Continuing Operations 1 % Commentary FY26 H1 FY25 H1 (A$’m ) Change • An ongoing focus on strong cost management and operational excellence in FY26 H1 has helped offset a Net revenue 2 68.0 68.7 (1%) slight decline in revenue, which was impacted by
Slide 3: Group EBITDA grew 15% and improved margin
Group EBITDA grew 15% and improved margin Continuing Operations 1 % Commentary FY26 H1 Performance (A$’m ) FY26 H1 FY25 H1 Change • Increase in Technology, THC Practice Net revenue 2 68.0 68.7 (1%) Healthcare & Consumer (THC) Practice EBITDA despite a small THC Practice Expenses (56.8) (57.7) 2% red
Slide 4: THC Practice EBITDA growth driven by strong performance of Australian agencies
Global THC Practice EBITDA growth driven by strong performance of Australian agencies FY26 H1 Performance Underlying Results Net Revenue 2 EBITDA 3 EBITDA Margin % % (A$’m ) FY26 H1 FY25 H1 FY26 H1 FY25 H1 FY26 H1 FY25 H1 Change Change Hotwire Global 33.5 39.6 (15%) 3.6 6.1 (40%) 10.8% 15.3% BMF 20.
Slide 5: Diversified revenue mix across industry and geography
Diversified revenue mix across industry and Global geography Practice revenue by industry Practice revenue by geography Practice revenue model Other Finance 3% 8% Services 8% USA Project 28% 39% Healthcare Technology Retainer - 13% & Telco Fixed Australia & Retail & 44% UK & 54% Asia Consumer Europe
Slide 6: Hotwire maintained double-digit margins during ongoing agency transformation
Hotwire maintained double -digit margins during ongoing Global agency transformation and challenging technology sector FY26 H1 Performance Commentary • Lower client spend due to a greater focus on AI investment and continued technology sector softness has impacted revenue • Strong cost optimisation
Slide 7: BMF delivered strong revenue growth and expanded margins
BMF delivered strong revenue growth and expanded margins FY26 H1 Performance Commentary • Calendar 2025 wins contributed to a strong financial performance in FY26 H1 • Margins continued to improve in the half, increasing to 23.2% from 21.2% in the prior half (FY25 H2) and significantly improved from
Slide 8: Orchard significantly grew EBITDA and revenue with strength in healthcare and consumer
Orchard significantly grew EBITDA and revenue with strength in both healthcare and consumer verticals FY26 H1 Performance Commentary • Orchard’s healthcare vertical has performed very strongly due to: • new drug launches with key client; • existing clients expanding their remit; and • new client win
Slide 9: Continued focus on agency and corporate cost efficiency underpinned EBITDA growth
A continued focus on both agency and corporate cost efficiency in FY26 H1 has underpinned EBITDA growth 1 Expense by segment (A$M, cons curr , continuing ops ) Commentary Technology, Healthcare and Consumer (THC) Practice • FY26 H1 reduction driven by Hotwire Global with additional cost initiatives
Slide 10: Key Financial Metrics
KEY FINANCIAL METRICS
Slide 11: Statutory profit & loss
Statutory profit & loss Continuing Operations 1 Commentary FY26 H1 FY25 H1 % Change (A$’m ) 12 for THC Practice of 70% (FY25 H1: 72%) • Staff costs ratio Net revenue 2 68.0 68.7 (1%) • Higher opex for continuing operations due to facilities cost Other income inflation and impact of FX rates 0.0 0.1
Slide 12: Significant items less than one third of FY25 H1
Significant items less than one third of FY25 H1 1 Continuing Operations FY26 H1 FY25 H1 Commentary (A$’m ) • Restructuring costs relate to ROI DNA Global Restructuring costs (1.0) (2.6) rebranding and realignment and Hotwire Europe centralisation Reassessment of useful life (0.3) (0.3) Fair value a
Slide 13: Healthy cash balance post OBMedia disposal
Healthy cash balance post OBMedia disposal Enero Group including discontinuing operations Commentary FY26 H1 FY25 H1 (A$’m ) EBITDA 7.4 15.7 • Cash conversion 10 at 45% of EBITDA (FY25 H1: 86%; 64% Movement in working capital (4.3) 0.1 continuing operations) driven by reduction of cash held on behal
Slide 14: Robust capital position maintained
Robust capital position maintained Balance Sheet 31 Dec 2025 30 Jun 2025 Commentary (A$’m ) • Net cash 11of $23.6m (June 2025: $27.5m) Cash 27.2 34.1 • Zero leverage with Net Debt/ EBITDA 0.0x Trade and other receivables 22.1 27.5 • $11.4m of $15m bank loan facility undrawn at Other assets 20.7 23.1
Slide 15: Appendix
APPENDIX
Slide 16: Segment results on an underlying basis
Segment results on an underlying basis Underlying Results Revenue EBITDA EBITDA Margin % % (A$’m ) FY26 H1 FY25 H1 FY26 H1 FY25 H1 FY26 H1 FY25 H1 Change Change Technology, Healthcare & 68.0 68.7 (1%) 11.2 10.9 3% 16.5% 15.9% Consumer Practice Corporate Costs - - - (3.3) (4.3) 22% - - Equity Incenti
Slide 17: Results by Geography
Results by Geography 1 Continuing Operations FY26 H1 FY25 H1 % Change (A$’m ) Revenue Australia and Asia 36.2 30.8 17% USA 19.1 22.9 (16%) UK and Europe 12.7 14.9 (15%) Total 68.0 68.7 (1%) EBITDA Australia and Asia 7.8 4.9 58% USA 3.0 4.1 (26%) UK and Europe 0.4 1.9 (77%) Total operating companies
Slide 18: Definitions
Definitions 1. Continuing operations: excludes OBMedia sold on 30 June 2025 2. Net revenue: gross revenue recognised in accordance with AASB 15 less directly attributable cost of sales 3. EBITDA: profit before interest, taxes, depreciation, amortisation and significant items 4. EBITDA Margin (Margin
Slide 19: Disclaimer
This document has been prepared by Enero Group Limited Except for any statutory liability which cannot be excluded, (Enero) and comprises written materials/slides for a each of Enero, its related companies and their respective presentation concerning Enero. This is not a prospectus, officers, employ